Small Scott A
Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Arch Neurol. 2008 Mar;65(3):323-8. doi: 10.1001/archneurol.2007.64.
During the tail end of the 20th century, a "golden period" in Alzheimer disease (AD) research, many of the pathogenic molecules of the autosomal dominant form of the disease were isolated. These molecular defects, however, do not exist in "sporadic" late-onset AD, the form of the disease that accounts for more than 95% of all cases. Pinpointing the pathogenic molecules of late-onset AD has, therefore, become an urgent goal, both for understanding disease mechanisms and for opening up novel therapeutic avenues. The retromer sorting pathway transports cargo along the endosome-trans-Golgi network, and retromer defects were first implicated in late-onset AD by a study that combined brain imaging with microarray. A range of studies have confirmed that defects in this pathway can play a pathogenic role in the disease. Herein, these findings will be reviewed, the details of the retromer sorting pathway will be discussed, and a biological model that can account for the disease's regional selectivity will be elaborated.
在20世纪末阿尔茨海默病(AD)研究的“黄金时期”,该疾病常染色体显性形式的许多致病分子被分离出来。然而,这些分子缺陷并不存在于“散发性”晚发型AD中,而这种疾病形式占所有病例的95%以上。因此,确定晚发型AD的致病分子已成为一个紧迫目标,这对于理解疾病机制和开辟新的治疗途径都很重要。逆向转运体分选途径沿着内体-反式高尔基体网络运输货物,一项将脑成像与微阵列相结合的研究首次表明逆向转运体缺陷与晚发型AD有关。一系列研究证实,该途径的缺陷可在疾病中发挥致病作用。在此,将对这些发现进行综述,讨论逆向转运体分选途径的细节,并阐述一个能够解释该疾病区域选择性的生物学模型。